Citadel Advisors’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,388
| Closed | -$933 | – | 6844 |
|
|
2023
Q2 | $933 | Hold |
1,388
| – | – | ﹤0.01% | 5629 |
|
|
2023
Q1 | $1.93K | Sell |
1,388
-151
| -10% | -$210 | ﹤0.01% | 5709 |
|
|
2022
Q4 | $1.94K | Buy |
1,539
+149
| +11% | +$188 | ﹤0.01% | 5885 |
|
|
2022
Q3 | $6K | Buy |
+1,390
| New | +$6K | ﹤0.01% | 5697 |
|
|
2022
Q2 | – | Sell |
-2,005
| Closed | -$24K | – | 7260 |
|
|
2022
Q1 | $24K | Sell |
2,005
-3,593
| -64% | -$43K | ﹤0.01% | 6111 |
|
|
2021
Q4 | $110K | Sell |
5,598
-3,822
| -41% | -$75.1K | ﹤0.01% | 5853 |
|
|
2021
Q3 | $245K | Buy |
9,420
+5,289
| +128% | +$138K | ﹤0.01% | 5207 |
|
|
2021
Q2 | $91K | Sell |
4,131
-6,957
| -63% | -$153K | ﹤0.01% | 6007 |
|
|
2021
Q1 | $259K | Buy |
+11,088
| New | +$259K | ﹤0.01% | 5174 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5767 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5460 |
|
|
2020
Q2 | – | Sell |
-2,553
| Closed | -$26K | – | 5470 |
|
|
2020
Q1 | $26K | Buy |
+2,553
| New | +$26K | ﹤0.01% | 4630 |
|
|
2019
Q2 | – | Sell |
-2,752
| Closed | -$106K | – | 5235 |
|
|
2019
Q1 | $106K | Buy |
+2,752
| New | +$106K | ﹤0.01% | 4086 |
|
|
2018
Q4 | – | Sell |
-512
| Closed | -$70K | – | 5071 |
|
|
2018
Q3 | $70K | Buy |
+512
| New | +$70K | ﹤0.01% | 3961 |
|
|
2018
Q1 | – | Sell |
-91
| Closed | -$11K | – | 4535 |
|
|
2017
Q4 | $11K | Sell |
91
-180
| -66% | -$21.8K | ﹤0.01% | 3809 |
|
|
2017
Q3 | $38K | Buy |
+271
| New | +$38K | ﹤0.01% | 3439 |
|
|
2017
Q2 | – | Sell |
-84
| Closed | -$20K | – | 4314 |
|
|
2017
Q1 | $20K | Hold |
84
| – | – | ﹤0.01% | 3525 |
|
|
2016
Q4 | $29K | Buy |
+84
| New | +$29K | ﹤0.01% | 3390 |
|